Navigation Links
The Effectiveness Of The Breast Cancer Drug By Pfizer

Pfizer has increased the survival rate of breast cancer patients by 63 percent with their latest drug compared to the standard regimes available . The clinical trial strengthens the case for administering the newer drug, exemestane, as a first option.// A study showed that women recovering from breast cancer lowered their chance of developing another tumor by 32 percent if they switched to exemestane after two or three years of tamoxifen treatment.

According to the research presented this week at a breast cancer conference , the median survival for patients taking exemestane was 10.9 months, compared with 6.7 months for patients on tamoxifen. About 44.2 percent of patients in the study had tumors that responded either partially or fully to exemestane , compared with 29.2 percent on tamoxifen. The difference was statistically significant. These reports have been substantiated by specialists in the field who began trying the drug in patients in 1989, well before it was approved.

Tamoxifen is sold under the brand name Nolvadex by AstraZeneca Plc and is usually taken for five years. Tamoxifen works by blocking the hormone estrogen, which can stimulate and feed the growth of breast cancer.

By contrast, exemestane was the first approved oral therapy that binds to an enzyme known as aromatase, which normally converts the hormone androgen into estrogen in postmenopausal women. The drug thereby curtails the actual supply of estrogen to the cancerous tumors that are dependent on it, rather than blocking estrogen after it is already produced. Pfizer markets exemestane under the brand name Aromasin.

Researchers say ,"These (studies) are pieces of the puzzle, and the puzzle is becoming clearer now."
'"/>




Page: 1

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. The Effectiveness Of Screening Tests Questioned
3. The Effectiveness Of Chickenpox Vaccine Questioned
4. The Effectiveness Of Antibacterial Products In Reducing Infection
5. The Effectiveness Of Cancer Drug In Women At Risk Of Developing Cancer
6. Effectiveness Of Prostate Cancer Test
7. Studying The Effectiveness Of Cough Syrups
8. The Effectiveness Of NSAIDs Evaluated
9. Effectiveness Of Infertility Treatments Questioned
10. Report on the Safety and Effectiveness of Melatonin supplements
11. The Effectiveness Of Inhaled Corticosteroids Studied
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
(Date:6/23/2016)... -- The vast majority of dialysis patients currently receive ... usually 3 times a week, with treatment times averaging ... equipment preparation and wait time.  This regimen can be ... who are elderly and frail.  Many elderly dialysis patients ... for some duration of time. Residents in ...
Breaking Medicine Technology: